Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.51M Sell
12,801
-1,782
-12% -$206K 0.11% 104
2026
Q1
$1.74M Buy
14,583
+1,942
+15% +$255K 0.15% 102
2025
Q4
$1.72M Buy
+12,641
New +$1.82M 0.14% 100

Other funds holding XYL

Callahan Advisors's XYL Position: Q2 2026 in Review

Callahan Advisors reduced its Xylem (XYL) stake by 12% in Q2 2026, selling an estimated $206K and leaving 12,801 shares worth $1.51M. The position accounts for 0.11% of the portfolio, ranked #104.

Callahan Advisors first reported a position in XYL in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.74M in Q1 2026. 456 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Callahan Advisors held 12,801 shares of Xylem worth $1.51M as of Q2 2026.
  • Callahan Advisors sold 1,782 Xylem shares in Q2 2026, an estimated $206K.
  • Xylem made up 0.11% of Callahan Advisors's portfolio in Q2 2026, its #104 holding.
  • Callahan Advisors first reported a position in Xylem in Q4 2025 and has held it in 3 quarters since.
  • Callahan Advisors's Xylem position peaked at $1.74M in Q1 2026.
  • 456 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Callahan Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.